StonvexLoading…
StonvexStonvexStonvexCore line items from ERNA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2020 2020-12-31 | Q3 2020 2020-09-30 | Q2 2020 2020-06-30 | Q1 2020 2020-03-31 |
|---|---|---|---|---|
Revenue | $5.80M | $4.63M | $3.15M | $2.39M |
Operating Income | $-7.25M | $-5.04M | $-3.03M | $-1.01M |
Net Income | $-7.29M | $-5.07M | $-3.05M | $-1.02M |
EPS (Diluted) | $-0.41 | $-0.29 | $-0.17 | $-0.06 |
Total Assets | $12.91M | $5.05M | $6.79M | $11.01M |
Total Liabilities | $5.25M | $4.56M | $4.86M | $7.17M |
Cash & Equivalents | $777.00K | $1.71M | $2.23M | $2.22M |
Free Cash Flow OCF − CapEx | $-8.14M | $-6.49M | $-4.08M | $-1.88M |
Shares Outstanding | 0 | 2.95M | 2.94M | 2.93M |